Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (64)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Matsuzaki, S.
Right arrow Articles by Yajima, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuzaki, S.
Right arrow Articles by Yajima, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 5, No. 6, 559-564, June 1999
© 1999 European Society of Human Reproduction and Embryology

Oestrogen receptor {alpha} and ß mRNA expression in human endometrium throughout the menstrual cycle

Sachiko Matsuzaki1,3, Takao Fukaya1, Takashi Suzuki2, Takashi Murakami1, Hironobu Sasano2 and Akira Yajima1

1 Department of Obstetrics & Gynecology and 2 Department of Pathology, Tohoku University School of Medicine, 1–1, Seiryo-machi, Aoba-ku, Sendai, 980–8574, Japan

We examined the localization of oestrogen receptor (ER) ß mRNA in the human endometrium throughout the menstrual cycle using non-radioactive in-situ hybridization with Brigati-tailed oligonucleotides. The findings were compared with those of ER{alpha} in order to examine the possible biological significance of ERß in the human endometrium. Both ER{alpha} and ERß mRNA expression were detected in all major human uterine cell types, including glandular epithelial cells, stromal cells and smooth muscle cells of the uterine wall, at every menstrual cycle stage. However, ER{alpha} mRNA expression was more prominent than that of ERß in all cell types throughout the menstrual cycle. In proliferative phase endometrium, ER{alpha} mRNA was expressed in both glandular epithelial and stromal cells, while ERß mRNA was expressed predominantly in glandular epithelial cells. Although the same pattern was observed in the secretory phase, both the ER{alpha} and ERß mRNA expression was relatively weaker. These results suggest that oestrogenic effects occur predominantly through ER{alpha}, but that ERß may also play a role in the modulation of oestrogenic action, especially on glandular epithelial cells in the human endometrium throughout the menstrual cycle.

endometrium/ER{alpha}/ERß/in-situ hybridization

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
S. Altmae, K. Haller, M. Peters, O. Hovatta, A. Stavreus-Evers, H. Karro, A. Metspalu, and A. Salumets
Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization
Mol. Hum. Reprod., August 1, 2007; 13(8): 521 - 526.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. A. Harris, K. L. Bruner-Tran, X. Zhang, K. G. Osteen, and C. R. Lyttle
A selective estrogen receptor-{beta} agonist causes lesion regression in an experimentally induced model of endometriosis
Hum. Reprod., April 1, 2005; 20(4): 936 - 941.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R. Pilka, H. Domanski, S. Hansson, P. Eriksson, and B. Casslen
Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26
Mol. Hum. Reprod., September 1, 2004; 10(9): 641 - 650.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
A. Vienonen, S. Miettinen, M. Blauer, P. M. Martikainen, E. Tomas, P. K. Heinonen, and T. Ylikomi
Expression of Nuclear Receptors and Cofacotrs in Human Endometrium and Myometrium
Reproductive Sciences, February 1, 2004; 11(2): 104 - 112.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
F. Goffin, C. Munaut, F. Frankenne, S. Perrier d'Hauterive, A. Beliard, V. Fridman, P. Nervo, A. Colige, and J.-M. Foidart
Expression Pattern of Metalloproteinases and Tissue Inhibitors of Matrix-Metalloproteinases in Cycling Human Endometrium
Biol Reprod, September 1, 2003; 69(3): 976 - 984.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. B. Pillai, J. M. Jones, and R. D. Koos
Treatment of Rats with 17{beta}-Estradiol or Relaxin Rapidly Inhibits Uterine Estrogen Receptor {beta}1 and {beta}2 Messenger Ribonucleic Acid Levels
Biol Reprod, December 1, 2002; 67(6): 1919 - 1926.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. O. D. Critchley, T. A. Henderson, R. W. Kelly, G. S. Scobie, L. R. Evans, N. P. Groome, and P. T. K. Saunders
Wild-Type Estrogen Receptor (ER{beta}1) and the Splice Variant (ER{beta}cx/{beta}2) Are Both Expressed within the Human Endometrium throughout the Normal Menstrual Cycle
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5265 - 5273.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
W. J. Hendry III, D. M. Sheehan, S. A. Khan, and J. V. May
Developing a Laboratory Animal Model for Perinatal Endocrine Disruption: The Hamster Chronicles
Experimental Biology and Medicine, October 1, 2002; 227(9): 709 - 723.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
F. Wieser, C. Schneeberger, G. Hudelist, C. Singer, C. Kurz, F. Nagele, C. Gruber, J.C. Huber, and W. Tschugguel
Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation
Mol. Hum. Reprod., July 1, 2002; 8(7): 644 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
X.-H. Li, H. Li, Z.-J. Xiao, and Y.-S. Piao
Divergent Effects of Retinoic Acids on the Expression of ER{alpha} and 17{beta}-Hydroxysteroid Dehydrogenase Type 2 in Endometrial Carcinoma Cells (RL 95-2)
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 640 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. O. D. Critchley, R. M. Brenner, T. A. Henderson, K. Williams, N. R. Nayak, O. D. Slayden, M. R. Millar, and P. T. K. Saunders
Estrogen Receptor {beta}, But Not Estrogen Receptor {{alpha}}, Is Present in the Vascular Endothelium of the Human and Nonhuman Primate Endometrium
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1370 - 1378.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
G. LECCE, G. MEDURI, M. ANCELIN, C. BERGERON, and M. PERROT-APPLANAT
Presence of Estrogen Receptor {beta} in the Human Endometrium through the Cycle: Expression in Glandular, Stromal, and Vascular Cells
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1379 - 1386.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
H. Wang, H. Eriksson, and L. Sahlin
Estrogen Receptors {alpha} and {beta} in the Female Reproductive Tract of the Rat During the Estrous Cycle
Biol Reprod, November 1, 2000; 63(5): 1331 - 1340.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. M. Klotz, S. C. Hewitt, K. S. Korach, and R. P. Diaugustine
Activation of a Uterine Insulin-Like Growth Factor I Signaling Pathway by Clinical and Environmental Estrogens: Requirement of Estrogen Receptor-{alpha}
Endocrinology, September 1, 2000; 141(9): 3430 - 3439.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Weihua, S. Saji, S. Makinen, G. Cheng, E. V. Jensen, M. Warner, and J.-A. Gustafsson
Estrogen receptor (ER) beta , a modulator of ERalpha in the uterus
PNAS, May 23, 2000; 97(11): 5936 - 5941.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Nisolle, S. Gillerot, F. Casanas-Roux, J. Squifflet, M. Berliere, and J. Donnez
Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy
Hum. Reprod., November 1, 1999; 14(11): 2844 - 2850.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.